We invite you to the 2nd Orphan Drugs Research & Commercialization Conference,
happening February 20-21, 2014 in San Diego, CA.
This meeting provides a forum for all
stakeholders, from researchers, industry leaders, patient advocacy
organizations, and regulatory experts to gather and share different perspectives
on how to best guide the field forward. The program will include presentations
on the latest scientific research, such as RNAi therapeutics and gene therapy;
pricing and reimbursement challenges; clinical endpoints; and much more.
Sessions for this year's meeting include:
Joint Session: Cell and Gene Therapy for
Rare Diseases: From Research to Regulatory
Emerging Therapeutics in Rare Diseases
Clinical Trials: Lessons
Learned & Other Considerations
Reaching the Markets &
Forming Strategic Partnerships
Advocating For & Engaging With Patients
Patient Registries in Orphan Drug
Navigating the Regulatory Landscape
Please join us for not only
presentations on the latest hot topics in the orphan drugs space, but networking
sessions where you will meet other stakeholders in the community to collaborate
and build meaningful relationships.
We hope to see you in San Diego!
The 2014 Advisory Committee